Reprogramming immunosuppressive myeloid cells facilitates immunotherapy for colorectal cancerWeiqiang Lü, Mingyao Liu|EMBO Molecular Medicine|2020Cited by 110
The lactate receptor HCAR1 drives the recruitment of immunosuppressive PMN-MDSCs in colorectal cancerJiacheng He, Weiqiang Lü, Yuanyuan Fu et al.|Nature Immunology|2025Cited by 54
Activation of orphan receptor GPR132 induces cell differentiation in acute myeloid leukemiaChunyang Yi, Weiqiang Lü, Jiacheng He et al.|Cell Death and Disease|2022Cited by 20
A Novel Small Molecular Prostaglandin Receptor EP4 Antagonist, L001, Suppresses Pancreatic Cancer MetastasisJiacheng He, Weiqiang Lü, Xian-Hua Lin et al.|Molecules|2022Cited by 17
Shikonin is a novel antagonist of prostaglandin E2 receptor 4 that targets myeloid-derived suppressor cellsYang Wang, Jiacheng He, Naijipu Abuduaini et al.|Genes & Diseases|2024Cited by 1